Journal of Hepatology Hepatology

Decoding primary refractoriness to atezolizumab plus bevacizumab in hepatocellular carcinoma: The myeloid frontier

Elsevier ·

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →